How should staff administer a split-specimen point-of-care urine drug screen cup correctly?
Short answer
Administering a split-specimen point-of-care urine screen cup requires collecting at least 45 milliliters of urine and confirming the temperature registers between 90°F and 100°F within four minutes. Staff must then lock the lid to separate the sample, peel the label, and read the test lines at five minutes. Results must not be read after ten minutes, and positive findings require laboratory confirmation.
To administer a split-specimen urine drug screen cup correctly, staff must verify donor identity, collect at least 45 milliliters of urine, confirm the temperature reads between 90°F and 100°F within four minutes, and interpret results at five minutes.
Point-of-care drug screening provides rapid preliminary results for clinics and workplace programs, but administrative errors risk sample tampering or false readings. Under workplace testing standards aligned with 49 CFR Part 40 guidelines, split collections preserve specimen integrity by dividing the sample into primary screening and secondary confirmation aliquots—which are separate portions of the same specimen.
If you only do one thing: Verify that the cup's built-in temperature strip reads between 90°F and 100°F (32°C to 38°C) within four minutes of receiving the sample before peeling any test result panels.
- Verify donor identity and secure collection area: Check a government-issued photo ID, have the donor empty pockets and remove bulky outerwear, and add bluing agent to the toilet water while securing external water sources.
- Collect adequate specimen volume: Hand the donor a sealed split-specimen cup and instruct them to provide a minimum of 45 milliliters (mL) of urine—at least 30 mL for primary screening and 15 mL for split confirmation.
- Verify temperature and integrity within four minutes: Confirm the liquid level reaches the minimum fill line, check that the temperature indicator registers between 90°F and 100°F, and visually inspect for abnormal color, clarity, or foreign substances.
- Secure the split specimen chamber: Tighten the screw-top lid until it locks to activate the internal split-specimen flow mechanism, preventing cross-contamination between the screening test strips and the sealed reserve chamber.
- Read point-of-care panel results at five minutes: Peel the privacy label covering the diagnostic strip windows, confirm the control line ("C") appears on every panel to validate test viability, and read drug results at five minutes, never reading past the 10-minute mark.
- Apply tamper-evident security seals: Affix the dated chain-of-custody seal over the cap and down the cup sides in the donor's presence, obtaining donor initials directly on the seal if the split portion requires laboratory confirmation.
- Watch out for: Reading drug strip results after 10 minutes, as evaporative dye migration can cause faint non-reactive lines to disappear and register as false presumptive positives.
- Watch out for: Accepting specimens falling outside 90°F to 100°F (32°C to 38°C), which indicates substitution or dilution and requires documenting the variance and initiating an immediate recollection under direct observation.
- Watch out for: Treating rapid cup results as a final diagnostic determination without sending presumptive positive split samples to a certified laboratory for secondary gas chromatography-mass spectrometry confirmation.
For protocol compliance, review facility standard operating procedures or consult a certified medical review officer before taking administrative action based on screening results.
